COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the resignation of senior management and financial director and the appo
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2014-025
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on the resignation of senior management, financial controller and new senior management and financial director
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
On March 26, 2014, the Board of Directors of Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “Company”) received the written resignation report of Deputy General Manager and Chief Financial Officer Mr. Xu Jifeng and Deputy General Manager of Production, Mr. Han Ming, Deputy General Manager Mr. Xu Jifeng, the chief financial officer, resigned from his post for personal reasons. Mr. Xu Jifeng will no longer hold any position in the company after he resigns. Mr. Han Ming, the deputy general manager of production, resigned due to work adjustment reasons. Mr. Han Ming will be the general manager of the Liuhe parent company. According to the "Company Law" and the relevant provisions of the company's "Articles of Association", Mr. Xu Jifeng and Mr. Han Ming's resignation application will take effect from the date of the resignation report served on the company's board of directors.
Reviewed by the Nomination Committee of the 5th Board of Directors of the Company, the company reviewed and approved the Proposal on Appointing Senior Management of the Company and the Proposal on Appointing the Chief Financial Officer of the Company at the 13th Meeting of the 5th Board of Directors on March 26, 2013. He agreed to hire Mr. Xu Daqing as the deputy general manager of sales and Mr. Zhang Zhongwei as the chief financial officer of the company. The term of office shall be from the date of the approval of the board of directors to the expiration of the fifth board of directors.
The independent directors of the company have issued independent opinions. The independent directors of the company unanimously agreed that the convening, convening and deputy general manager and chief financial officer of the board of directors are fair, just and legal, in line with the Company Law and the Securities Law. 》, “Shenzhen Stock Exchange Listing Rules”, “Articles of Association” and other relevant regulations, agreed to hire Mr. Xu Daqing as the deputy general manager of sales, Mr. Zhang Zhongwei as the company's financial controller.
Attachment: Resume of newly nominated personnel
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
March 27, 2014
Jilin Zixin Pharmaceutical Co., Ltd.
Resume of the 5th Senior Management Candidate
Mr. Zhang Zhongwei, Han nationality, born on March 19, 1978, member of the Communist Party of China, bachelor degree, Chinese CPA. From September 2001 to August 2012, he worked as a senior project manager at Zhongzhun Certified Public Accountants Co., Ltd.; from August 2012 to February 2014, he served as deputy general manager of Yadong Investment Management Co., Ltd. in Jilin Province; joined in March 2014 Our company. Mr. Zhang Zhongwei does not have any relationship with the Company or the controlling shareholder, actual controller and other directors, supervisors and senior management personnel; does not hold shares of the company; has not been punished by the China Securities Regulatory Commission and other relevant departments and the stock exchange.
Mr. Xu Daqing, Korean nationality, born on May 15, 1977, bachelor degree, accounting major, 2000-2001 in Jilin Province, Dunhua Changbai Mountain Biological Products Co., Ltd. as an accountant; 2001-2003 in Jilin Tiansanqi Pharmaceutical Co., Ltd. is a regional manager; self-operated agent products from 2003 to 2005; since 2005, he has served as director of pharmaceutical sales. Mr. Xu Daqing has no relationship with the Company or the controlling shareholder, actual controller and other directors, supervisors and senior management personnel; does not hold shares of the company; has not been punished by the China Securities Regulatory Commission and other relevant departments and the securities exchange .